Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Medical Genetics · Peripheral demyelinating neuropathy–central dysmyelinating leukodystrophy–Waardenburg syndrome–Hirschsprung disease (PCWH)

Understanding PCWH and Your Child's Diagnosis

At a Glance

PCWH is a rare SOX10-related condition in the Waardenburg-Shah syndrome spectrum that can affect hearing, pigmentation, bowel nerve development, and the brain and peripheral nerves. Features vary, so care is individualized and genetic counseling helps clarify inheritance.

Finding out your child has PCWH is overwhelming. This condition is a rare, complex presentation within the Waardenburg-Shah syndrome (also known as Waardenburg syndrome type 4) spectrum [1][2]. While it shares many features with other types of Waardenburg syndrome, such as changes in hearing or pigmentation, PCWH is unique because it also affects how the nervous system develops and functions [3].

Decoding the Acronym

The name PCWH is not a single word but a “map” of the different areas of the body the condition can affect. Each letter stands for a specific medical finding:

  • P: Peripheral demyelinating neuropathy. This affects the peripheral nerves—the “wires” that carry signals between the brain and the rest of the body. Demyelinating means the protective coating (myelin) on these nerves is missing, altered, or damaged, which can lead to muscle weakness or trouble with coordination [4][5].
  • C: Central dysmyelinating leukodystrophy. This involves the brain and spinal cord (the central nervous system). Dysmyelinating refers to the brain’s altered ability to properly form myelin. A leukodystrophy is a condition that specifically affects this “white matter” or insulation of the brain [4][6].
  • W: Waardenburg syndrome. This refers to the characteristic pigment changes (such as a white forelock of hair or different colored eyes) and sensorineural hearing loss often seen in this group of conditions [7][2].
  • H: Hirschsprung disease. This is a condition where certain nerve cells are missing from the end of the bowel, making it very difficult for a child to pass stool. This often requires surgery shortly after birth [8][9].

One Gene, Many Roles

The biological “root” of PCWH is a mutation in a gene called SOX10 [1]. To understand why one gene affects so many different parts of the body, it helps to look at how a baby develops in the womb.

Early in development, a special group of “starter cells” called neural crest cells travel throughout the body to become different things [3]. SOX10 acts like a master regulator, giving these cells the instructions they need to reach their destination and do their jobs. It tells them how to become:

  • Melanocytes: Cells that create pigment in the skin, hair, and eyes [10].
  • Enteric nerves: The “brain of the gut” that controls digestion [8].
  • Schwann cells: The cells that wrap the peripheral nerves in protective myelin [4].

In addition to its work with neural crest cells, SOX10 is also essential for oligodendrocytes [6]. These cells are responsible for creating the myelin insulation in the brain and spinal cord. When the SOX10 gene has a mutation, these instructions are garbled, which is why PCWH can affect the skin, the gut, the hearing, and both the peripheral and central nervous systems simultaneously [3][4].

Variability and the PCW Variant

PCWH is generally a severe SOX10-associated phenotype, but it does not look the same in every child [7]. Doctors use the term phenotypic variability to describe how the symptoms can range from mild to severe, even among people with the same genetic mutation [11][12].

Some children may have all four parts of the acronym, while others may only have a few. For example, some children have the neurological and Waardenburg features but do not have Hirschsprung disease. This version is often referred to as PCW [1][3].

Because the condition is so variable, your child’s care team will focus on their specific symptoms. This may include looking for “hidden” features, such as vestibular dysfunction (balance issues related to the inner ear) or anosmia (an inability to smell), which are commonly reported in SOX10-related conditions but can be easily overlooked in young children [13][14].

Understanding Rarity and Inheritance

While Waardenburg syndrome type 4 is a very rare group of conditions, the PCWH neurologic phenotype is even more specific and rare [7]. SOX10-related disease is generally inherited in an autosomal dominant pattern. In many cases, the SOX10 mutation is de novo, meaning it happened for the first time in the child and was not passed down from the parents [1]. However, it can also be inherited; a parent carrying the variant has a 50% chance of passing it on.

Sometimes a parent may have mosaicism, where the mutation is present in only some of their cells, which might cause them to have very mild symptoms—or none at all—that only become clear after their child is diagnosed [15][16]. A negative blood test in a parent does not entirely eliminate recurrence risk due to the possibility of germline mosaicism. Testing for parents and genetic counseling are standard parts of the genetic evaluation to help understand the family’s specific situation [17].

Common questions in this guide

What does PCWH stand for?
PCWH stands for peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease. The acronym summarizes the nerve, brain and spinal cord, hearing and pigment, and bowel features that may occur in this SOX10-related condition.
What gene causes PCWH?
PCWH is caused by a disease-causing change, or variant, in the SOX10 gene. SOX10 helps developing cells form pigment-producing cells, bowel nerves, peripheral-nerve myelin, and brain and spinal-cord myelin, so one variant can affect several body systems.
Will every child with PCWH develop Hirschsprung disease?
No. PCWH features are variable, and some children have the PCW form with neurologic and Waardenburg features but without Hirschsprung disease. A child’s care team should assess the child’s symptoms rather than assume every feature is present.
What signs can PCWH cause in children?
Children may have hearing loss or pigment changes such as a white forelock or differently colored eyes, along with muscle weakness or coordination problems. Balance difficulties, a reduced sense of smell, and trouble passing stool can also occur, but the combination and severity vary.
Is PCWH inherited from a parent?
SOX10-related disease usually follows an autosomal dominant pattern, but many variants occur de novo, meaning they arise for the first time in the child. If a parent carries the variant, each pregnancy has a 50% chance of inheriting it; mosaicism can make a parent’s symptoms mild or absent, so genetic counseling and parent testing are important.
What testing should parents consider after a child is diagnosed with PCWH?
Parents may be offered SOX10 testing and genetic counseling to determine whether the child’s variant was inherited or arose de novo. Testing can sometimes identify mosaicism, although a negative blood test does not completely exclude germline mosaicism. The care team can also prioritize baseline assessments based on the child’s symptoms.

Get notified when new evidence is published on Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Novel SOX10 Mutations in Waardenburg Syndrome: Functional Characterization and Genotype-Phenotype Analysis.

    Thongpradit S, Jinawath N, Javed A, et al.

    Frontiers in genetics 2020; (11()):589784 doi:10.3389/fgene.2020.589784.

    PMID: 33362852
  2. 2

    A de novo deletion mutation in SOX10 in a Chinese family with Waardenburg syndrome type 4.

    Wang X, Zhu Y, Shen N, et al.

    Scientific reports 2017; (7()):41513 doi:10.1038/srep41513.

    PMID: 28128317
  3. 3

    SOX10: 20 years of phenotypic plurality and current understanding of its developmental function.

    Pingault V, Zerad L, Bertani-Torres W, Bondurand N

    Journal of medical genetics 2022; (59(2)):105-114 doi:10.1136/jmedgenet-2021-108105.

    PMID: 34667088
  4. 4

    Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH.

    Ito Y, Inoue N, Inoue YU, et al.

    Neurobiology of disease 2015; (80()):1-14.

    PMID: 25959061
  5. 5

    Sox8 and Sox10 jointly maintain myelin gene expression in oligodendrocytes.

    Turnescu T, Arter J, Reiprich S, et al.

    Glia 2018; (66(2)):279-294 doi:10.1002/glia.23242.

    PMID: 29023979
  6. 6

    Myrf guides target gene selection of transcription factor Sox10 during oligodendroglial development.

    Aprato J, Sock E, Weider M, et al.

    Nucleic acids research 2020; (48(3)):1254-1270 doi:10.1093/nar/gkz1158.

    PMID: 31828317
  7. 7

    Neurological Waardenburg-Shah syndrome: a diagnostic challenge in a child with skin hypopigmentation and neurological manifestation.

    Ng BW, Lee JS, Toh TH, Ngu LH

    BMJ case reports 2022; (15(6)) doi:10.1136/bcr-2022-250360.

    PMID: 35725288
  8. 8

    Direct Interaction of Sox10 With Cadherin-19 Mediates Early Sacral Neural Crest Cell Migration: Implications for Enteric Nervous System Development Defects.

    Huang T, Hou Y, Wang X, et al.

    Gastroenterology 2022; (162(1)):179-192.e11 doi:10.1053/j.gastro.2021.08.029.

    PMID: 34425092
  9. 9

    A patient with peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and severe hypoganglionosis associated with a novel SOX10 mutation.

    Akutsu Y, Shirai K, Takei A, et al.

    American journal of medical genetics. Part A 2018; (176(5)):1195-1199 doi:10.1002/ajmg.a.38657.

    PMID: 29681101
  10. 10

    Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.

    Su Z, Zheng X, Zhang X, et al.

    Journal of dermatological science 2017; (85(3)):216-225 doi:10.1016/j.jdermsci.2016.12.002.

    PMID: 27955842
  11. 11

    A novel frameshift mutation in SOX10 causes Waardenburg syndrome with peripheral demyelinating neuropathy, visual impairment and the absence of Hirschsprung disease.

    Burke EA, Reichard KE, Wolfe LA, et al.

    American journal of medical genetics. Part A 2020; (182(5)):1278-1283 doi:10.1002/ajmg.a.61542.

    PMID: 32150337
  12. 12

    Genetic Variability of SOX10-Related Disorders within an Italian Family: Straddling the Line between Kallmann and Waardenburg Syndrome.

    Graziani L, Carriero ML, Pozzi F, et al.

    Molecular syndromology 2024; (15(4)):339-346 doi:10.1159/000536574.

    PMID: 39119450
  13. 13

    Vestibular Deficit in Patients with Waardenburg Syndrome.

    Benifla M, Serey-Gaut M, Bois E, et al.

    Biomedicines 2025; (13(8)) doi:10.3390/biomedicines13082021.

    PMID: 40868272
  14. 14

    Phenotypic continuum between Waardenburg syndrome and idiopathic hypogonadotropic hypogonadism in humans with SOX10 variants.

    Rojas RA, Kutateladze AA, Plummer L, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(4)):629-636 doi:10.1038/s41436-020-01051-3.

    PMID: 33442024
  15. 15

    HSP and deafness: Neurocristopathy caused by a novel mosaic SOX10 mutation.

    Donkervoort S, Bharucha-Goebel D, Yun P, et al.

    Neurology. Genetics 2017; (3(3)):e151 doi:10.1212/NXG.0000000000000151.

    PMID: 28534044
  16. 16

    Clinical Characteristics and Identification of Pathogenic Variant in a Large Chinese Family With Waardenburg Syndrome.

    Hou F, Li Y, Cao L, et al.

    Molecular genetics & genomic medicine 2025; (13(9)):e70134 doi:10.1002/mgg3.70134.

    PMID: 40879289
  17. 17

    A novel frameshift mutation of SOX10 identified in Waardenburg syndrome type 2.

    Han W, Yang R, Chen X, et al.

    Human molecular genetics 2025; (34(8)):668-672 doi:10.1093/hmg/ddaf010.

    PMID: 39849854

This page is for informational purposes only and does not constitute medical advice. Your child’s genetics and neurology team should interpret the SOX10 result and guide evaluations, testing, and care.